SecBot SecBot
3 ·Filed Oct 28, 2026

XBIT

XBiotech Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed1d 6h ago SEC0001193125-26-436039
Form 3: initial insider ownership statement
Actionable Insight • Neutral

Monitor the contemporaneous Form 4 for details of the option grant to assess insider alignment and potential dilution. The Form 3 itself is a routine administrative filing with no immediate trading signal.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled: T+1d
XBIT ▼ -2.51% at T+1d
NEUTRAL call -2.51% · α vs SPY -2.13% · entry $1.99 → $1.94
Next anchor: T+5d in 5d
Entry = T+0 close
Oct 28, 2026
via day close
T+1d
-2.51%
call -2.51% · α -2.13%
$1.94
settled 14h ago
T+5d
Pending
in 5d
T+20d
Pending
in 26d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

Jan-Paul Simard, the newly appointed Co-Chief Executive Officer of XBiotech Inc., filed a Form 3 initial statement of beneficial ownership, reporting no securities or derivative securities beneficially owned prior to a contemporaneous option grant. The filing is a routine administrative step for a new insider.

Key Facts

  • Jan-Paul Simard filed a Form 3 initial statement of beneficial ownership on 2026-10-28, with a period of report of 2026-10-23.
  • Simard is listed as Co-Chief Executive Officer of XBiotech Inc.
  • The filing states no securities or derivative securities were beneficially owned prior to the option grant set forth in a contemporaneous Form 4.
  • The filing is a routine insider onboarding requirement with no material financial data.

Financial Impact

No financial impact; the filing reports zero beneficial ownership prior to an option grant.

Risk Factors

  • No material risks identified from this filing; it is a standard initial ownership disclosure.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001193125-26-436039
Document: 0001193125-26-436039-index.html0001193125-26-436039
Document: 0001193125-26-436039.txt0001193125-26-436039
4 reports for XBIT
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for XBIT, sortable and filterable
TypeNow
Oct 28, 2026
1d ago
3
NEUTRAL ★ 2/10
$1.99awaiting T+5awaiting T+5$1.94 (−2.51%)
Oct 26, 2026
3d ago
8-K
NEUTRAL ★ 3/10
$1.85awaiting T+5awaiting T+5$1.94 (+4.86%)
Oct 2, 2026
27d ago
DEF 14A
BEARISH ★ 5/10
$2.19 $2.29▼ −4.57%▼ −3.41%$1.94 (+11.42%)
Apr 29, 2026
26w ago
10-K/A
NEUTRAL ★ 2/10
$2.52 $2.55▲ +1.19%▼ −1.92%$1.94 (−23.02%)
Showing 4 of 4

US Market Status

Market Closed · Opens Mon (59h 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 28, 2026